Much of the worlds population, including parts of Africa, Asia and South America, may not have access to the COVID-19 vaccine. This is because the vaccines must be stored at freezing, or below freezing temperatures and clinics in these areas don’t have access to cold-storage equipment. Some developers of the vaccine are hoping to create one that can be stored at normal refrigeration temperatures to help curb this problem.
Within a matter of months, it appears we have developed an effective vaccine for COVID-19 – a truly incredible accomplishment. With both Pfizer and Moderna